Superiority of intranasal over systemic administration of bioengineered soluble ACE2 for survival and brain protection against SARS-CoV-2 infection https://www.biorxiv.org/content/10.1101/2022.12.05.519032v1?med=mas
Superiority of intranasal over systemic administration of bioengineered soluble ACE2 for survival and brain protection against SARS-CoV-2 infection https://www.biorxiv.org/content/10.1101/2022.12.05.519032v1?med=mas